Position in MRNA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,003
+$1,923 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#650
of 772 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHELSEA COUNSEL CO holds $1,741,341 across 4 Biotechnology names. MRNA ranks #3 (0.4% of the industry book) .
All Filings in MRNA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,003 | 100 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $5,080 | 100 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,949 | 100 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $2,634 | 102 | Shares | Sole | 2025-11-25 | |
| 2025-06-30 | $2,814 | 102 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $2,891 | 102 | Shares | Sole | 2025-05-22 | |
| 2024-12-31 | $285,197 | 6,859 | Shares | Sole | 2025-02-27 | |
| 2024-09-30 | $494,809 | 7,404 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $954,631 | 8,039 | Shares | Sole | 2024-11-21 | |
| 2024-03-31 | $429,863 | 4,034 | Shares | Sole | 2024-06-17 | |
| 2023-12-31 | $420,872 | 4,232 | Shares | Sole | 2024-02-21 | |
| 2023-09-30 | $597,222 | 5,782 | Shares | Sole | 2023-11-22 | |
| 2023-06-30 | $711,018 | 5,852 | Shares | Sole | 2023-11-22 | |
| 2023-03-31 | $887,999 | 5,782 | Shares | Sole | 2023-05-19 | |
| 2022-12-31 | $1,038,562 | 5,782 | Shares | Sole | 2023-02-23 | |
| 2022-09-30 | $733,386 | 6,202 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $893,098 | 6,252 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,099,018 | 6,380 | Shares | Sole | 2022-05-24 | |
| 2021-12-31 | $1,626,741 | 6,405 | Shares | Sole | 2022-05-23 | |
| No filing history on record for this holder in this stock. | ||||||